Underrepresentation of women as participants and researchers in CV clinical trials remains a problem, asserts a review ...

After guideline changes, aspirin use dropped off overall, even for higher-risk patients in whom it might still be considered.

A study suggests that those under age 65 may need no restrictions at all, but more data would help clarify the issue.

Much has changed since the 2013 document came out, with new information on pacing devices, techniques, and more.